[
  {
    "ts": null,
    "headline": "Humana Benefits From Rising Premiums Amid High Benefit Ratio",
    "summary": "HUM gains from rising premiums, Medicare growth and CenterWell expansion, but faces pressure from high benefit ratios and costs.",
    "url": "https://finnhub.io/api/news?id=17c5ae4e9ef311cdde04e1be6773e6e2e1e3659f6da6f6bc1994b078999af192",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759414800,
      "headline": "Humana Benefits From Rising Premiums Amid High Benefit Ratio",
      "id": 136960351,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "HUM gains from rising premiums, Medicare growth and CenterWell expansion, but faces pressure from high benefit ratios and costs.",
      "url": "https://finnhub.io/api/news?id=17c5ae4e9ef311cdde04e1be6773e6e2e1e3659f6da6f6bc1994b078999af192"
    }
  },
  {
    "ts": null,
    "headline": "Cantor Fitzgerald Reaffirms Its Overweight rating and $400 Price Target on Elevance Health, Inc. (ELV)",
    "summary": "Elevance Health, Inc. (NYSE:ELV) is one of the 20 NYSE Stocks with the Lowest P/E Ratios. As 2026 Marketplace rates were set, Cantor Fitzgerald reaffirmed its Overweight rating and $400 price target, drawing attention to Elevance Health, Inc. (NYSE:ELV) on September 16, 2025. According to the company, Elevance Health, Inc. (NYSE:ELV)’s weighted-average estimate is only […]",
    "url": "https://finnhub.io/api/news?id=bfdecfaca2f5794aed333e4219ee90dccd3c77785251938609f9edb3a77c5ec2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759364427,
      "headline": "Cantor Fitzgerald Reaffirms Its Overweight rating and $400 Price Target on Elevance Health, Inc. (ELV)",
      "id": 136952447,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Elevance Health, Inc. (NYSE:ELV) is one of the 20 NYSE Stocks with the Lowest P/E Ratios. As 2026 Marketplace rates were set, Cantor Fitzgerald reaffirmed its Overweight rating and $400 price target, drawing attention to Elevance Health, Inc. (NYSE:ELV) on September 16, 2025. According to the company, Elevance Health, Inc. (NYSE:ELV)’s weighted-average estimate is only […]",
      "url": "https://finnhub.io/api/news?id=bfdecfaca2f5794aed333e4219ee90dccd3c77785251938609f9edb3a77c5ec2"
    }
  }
]